Castle Biosciences (FRA:086) Total Tax Payable: €4.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:086 Castle Biosciences Inc FRA:086
80 GF Score
Price €22.80
GF Value €21.14
! 4 Warning Signs
View Full Analysis

What is Castle Biosciences Total Tax Payable?

Castle Biosciences FRA:086 80 Total Tax Payable is €4.0 Mil as of Jun. 2026. GuruFocus rates FRA:086 with a GF Score™ of 80/100 and a GF Value™ of €21.14. The stock has 4 warning signs investors should review.

Castle Biosciences's Total Tax Payable for the quarter that ended in Jun. 2026 was €4.0 Mil.

Castle Biosciences's quarterly Total Tax Payable stayed the same from Dec. 2025 (€0.0 Mil) to Mar. 2026 (€0.0 Mil) but then increased from Mar. 2026 (€0.0 Mil) to Jun. 2026 (€4.0 Mil).

Castle Biosciences's annual Total Tax Payable declined from Dec. 2023 (€0.4 Mil) to Dec. 2024 (€0.0 Mil) but then stayed the same from Dec. 2024 (€0.0 Mil) to Dec. 2025 (€0.0 Mil).

Castle Biosciences Total Tax Payable Related Terms

Castle Biosciences Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Castle Biosciences's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Castle Biosciences Total Tax Payable Chart

Castle Biosciences Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.37 0.00 0.00

Castle Biosciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.03 1.06 0.00 0.00 3.99
FRA:086
80GF Score
Castle Biosciences Inc FRA:086
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Castle Biosciences Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of €4.0 Mil mean?
Castle Biosciences (FRA:086) has a Total Tax Payable of €4.0 Mil as of Jun. 2026. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Castle Biosciences and its competitors.
Is Castle Biosciences' Total Tax Payable too high?
Castle Biosciences' current Total Tax Payable is €4.0 Mil. Overall, Castle Biosciences has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Castle Biosciences' Total Tax Payable compare to OPK and FLGT?
Castle Biosciences' Total Tax Payable of €4.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Medical Diagnostics & Research company?
A good Total Tax Payable depends on the Medical Diagnostics & Research industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Castle Biosciences and its competitors. Castle Biosciences's current Total Tax Payable is €4.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Castle Biosciences stock overvalued right now?
Castle Biosciences (FRA:086) has a current Total Tax Payable of €4.0 Mil. The stock's GF Value™ is €21.14, compared to a current price of €22.80 — trading 7.9% above its estimated fair value. The current Total Tax Payable is €4.0 Mil. Castle Biosciences' overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Castle Biosciences (FRA:086), the current Total Tax Payable is €4.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Castle Biosciences (FRA:086) Overvalued in 2026?

Based on GuruFocus' analysis, Castle Biosciences stock appears to be overvalued. The current stock price of €22.80 is trading 7.9% above its estimated GF Value™ of €21.14.

Key valuation signals for FRA:086:

  • Total Tax Payable: €4.0 Mil
  • GF Value™: €21.14 vs. price of €22.80 (7.9% above fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the FRA:086 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Castle Biosciences Business Description

Other Exchanges CSTL:USA
Address 1500 West Parkwood Avenue, Suite 401, Friendswood, TX, USA, 77546
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
80GF Score

Get the complete analysis for FRA:086

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.80
Price
€21.14
GF Value